C12N 2740/12034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2740/12034 (Use of virus or viral component as vaccine) appears on 5 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 9
- Assignees
- 5
- Inventors
- 15
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 2 | 1 |
| 2025 | 0 | 0 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- HERV-K (HML-2) Env analog fusion proteins for antigen specific immunotherapy and methods of use29 Sep 2026US 12,747,270 B2Twilight Bioscience, Inc.
- HERV-K (HML-2) Env analog fusion proteins for antigen specific immunotherapy and methods of use4 Aug 2026US 12,698,309 B2Twilight Bioscience, Inc.
- Mammary tumor virus vaccine9 Jul 2024US 12,029,783 B2Virago Vax Inc.
- Mammary tumor virus suppression25 Jun 2024US 12,016,844 B2Virago Vax Inc.
- Methods for generation of antibodies8 Oct 2013US 8,551,968 B2National Jewish Health
- Herv-k (hml-2) env analog fusion proteins for antigen specific immunotherapy and methods of use5 Feb 2026US 2026/0035414 A1Twilight Bioscience, Inc.
- Herv-k (hml-2) env analog fusion proteins for antigen specific immunotherapy and methods of use5 Feb 2026US 2026/0035415 A1Twilight Bioscience, Inc.
- Immunogenic probiotic compositions and methods of use including in vaccination22 Feb 2024US 2024/0058440 A1Elanco US Inc.
- Mammary tumor virus suppression7 Jan 2021US 2021/0000800 A1Virago Vax Inc.
- Mammary tumor virus vaccine14 Nov 2019US 2019/0343938 A1Virago Vax Inc.
Most cited
By later US patents